Connect with us

Hi, what are you looking for?

Economy

New coronavirus variant identified in New York — researchers

Coronavirus-covid19
The new variant, known as B.1.526, shares some worrying characteristics with B.1.351, the variant first identified in South Africa, and P.1., which was first identified in Brazil. Several studies have suggested that those new variants are more resistant to some existing vaccines than earlier versions of the coronavirus.

A new coronavirus variant that shares some similarities with a more transmissible and intractable variant discovered in South Africa is on the rise in New York City, researchers said on Wednesday.

The new variant, known as B.1.526, was first identified in samples collected in New York in November, and by mid-February represented about 12% of cases, researchers at Columbia University Vagelos College of Physicians and Surgeons, said on Wednesday.

The variant was also described in research published online this week by the California Institute of Technology. Neither study has been reviewed by outside experts.

The Columbia researchers said an analysis of publicly available databases did not show a high prevalence of coronavirus variants recently identified in South Africa and Brazil in case samples from New York City and surrounding areas.

“Instead we found high numbers of this home-grown lineage,” Dr. Anne-Catrin Uhlemann, assistant professor in the division of infectious diseases at Columbia University’s College of Physicians and Surgeons, said in a statement.

The Columbia study found that B.1.526 shares some worrying characteristics with B.1.351, the variant first identified in South Africa, and P.1., which was first identified in Brazil. Several studies have suggested that those new variants are more resistant to some existing vaccines than earlier versions of the coronavirus.

The researchers said the main concern is a change in one area of the virus’ spike protein, called E484K, that is present in all three variants. The E484K mutation is believed to weaken the body’s immune response to the virus.

Studies have shown that recently launched coronavirus vaccines are still likely to neutralize the virus and protect against severe illness, even for infections with new variants. Vaccine makers are also working to develop booster shots to combat mutated versions of the virus. — Deena Beasley/Reuters

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Investing

Lowering VAT charges on fuel may be politically attractive but is not good news for those who will struggle the most, say leading tax...

Investing

An estimated 3 per cent of the workforce was signed off in late December and a fifth of businesses reported increased cancellations amid the...

Investing

Mark Zuckerberg could be forced to pay most British Facebook users about £50 each if a landmark legal action alleging that the site abused...

Investing

France has reopened its borders to British tourists after ministers in Paris eased restrictions on non-essential travel. From this morning, Britons travelling to the...

Investing

People struck down with the Omicron variant of the coronavirus are buying so much paracetamol that supplies are running low in many shops. Official...

Investing

Covid Passports are to be abandoned within days after Sajid Javid effectively killed off the policy. The health secretary has concluded that Covid-19 certification...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Investing

Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.